Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a significant decrease in short interest in September. As of September 15th, there was short interest totalling 3,700 shares, a decrease of 58.0% from the August 31st total of 8,800 shares. Based on an average daily trading volume, of 34,400 shares, the days-to-cover ratio is currently 0.1 days.

Ocean Biomedical Stock Up 29.3 %

Shares of OCEAW traded up $0.01 during mid-day trading on Friday, hitting $0.05. 38,094 shares of the stock were exchanged, compared to its average volume of 43,514. The firm has a 50-day moving average of $0.04 and a two-hundred day moving average of $0.09. Ocean Biomedical has a 52-week low of $0.02 and a 52-week high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.